Clinical Trial

Safety and Performance Evaluation of the SAVA Continuous Glucose Monitor for Effective Glucose Detection

Study acronym: SPEED
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to evaluate the safety and performance of the SAVA Continuous Glucose Monitor across glucose ranges over a period of 15-day wear in adults over 18 years of age with Type 1 Diabetes. This is a pilot study, so the main purposes are to collect preliminary data for future studies, assess comfort and safety, and explore the accuracy of the CGM against references and benchmarks.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-06-30.
Trial Details
NCT Number NCT07679347
Lead Sponsor SAVA Technologies Ltd.
Conditions Type 1 Diabetes Mellitus
Enrollment 20 participants
Start Date 2026-08
Primary Completion 2026-09 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2026-07-07